Carrie Lachance Purchases 1,967 Shares of InfuSystem Holdings, Inc. (NYSE:INFU) Stock

InfuSystem Holdings, Inc. (NYSE:INFU - Get Free Report) COO Carrie Lachance acquired 1,967 shares of the company's stock in a transaction that occurred on Friday, May 16th. The stock was bought at an average price of $6.10 per share, with a total value of $11,998.70. Following the acquisition, the chief operating officer now directly owns 190,212 shares of the company's stock, valued at $1,160,293.20. The trade was a 1.04% increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Carrie Lachance also recently made the following trade(s):

• On Thursday, May 15th, Carrie Lachance acquired 1,165 shares of InfuSystem stock. The stock was bought at an average price of $6.00 per share, with a total value of $6,990.00.

InfuSystem Trading Down 6.7%

Shares of InfuSystem stock traded down $0.39 during trading hours on Friday, hitting $5.41. The company's stock had a trading volume of 175,434 shares, compared to its average volume of 93,988. InfuSystem Holdings, Inc. has a 12 month low of $4.61 and a 12 month high of $9.97. The stock has a 50 day moving average of $5.30 and a 200 day moving average of $7.11. The company has a market capitalization of $113.70 million, a PE ratio of 90.18 and a beta of 1.73. The company has a debt-to-equity ratio of 0.50, a current ratio of 1.98 and a quick ratio of 1.59.

Institutional Inflows and Outflows

A number of hedge funds have recently modified their holdings of INFU. BNP Paribas Financial Markets grew its holdings in shares of InfuSystem by 67.9% during the fourth quarter. BNP Paribas Financial Markets now owns 6,844 shares of the company's stock worth $58,000 after buying an additional 2,768 shares in the last quarter. Jump Financial LLC acquired a new position in InfuSystem during the first quarter valued at approximately $58,000. Wells Fargo & Company MN boosted its position in InfuSystem by 51.7% during the fourth quarter. Wells Fargo & Company MN now owns 9,286 shares of the company's stock valued at $78,000 after purchasing an additional 3,165 shares during the last quarter. Legato Capital Management LLC acquired a new stake in shares of InfuSystem in the fourth quarter valued at approximately $85,000. Finally, Summit Global Investments acquired a new stake in shares of InfuSystem in the fourth quarter valued at approximately $86,000. 71.13% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

INFU has been the subject of several recent analyst reports. Sidoti upgraded InfuSystem to a "strong-buy" rating in a report on Tuesday, March 18th. Wall Street Zen downgraded InfuSystem from a "strong-buy" rating to a "buy" rating in a report on Wednesday, May 14th. Finally, B. Riley upgraded InfuSystem to a "strong-buy" rating in a report on Thursday, May 8th.

About InfuSystem

InfuSystem Holdings, Inc, through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Patient Services and Device Solutions. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states.